Drug | Findings |
---|---|
Dipeptidyl peptidase-4 inhibitors | |
Alogliptin | Cardiovascular safety Heart failure caution |
Linagliptina | Results not available |
Saxagliptin | Cardiovascular safety Heart failure caution |
Sitagliptin | Cardiovascular safety |
Glucagon-like peptide-1 receptor agonists | |
Albiglutidea | Results not available |
Dulaglutidea | Results not available |
Exenatidea | Results not available |
Liraglutideb | Cardiovascular benefit |
Lixisenatide | Cardiovascular safety |
Semaglutideb,c | Cardiovascular benefit |
Sodium-glucose cotransporter-2 inhibitors | |
Canagliflozina | Cardiovascular benefit Amputation caution |
Dapagliflozina | Results not available |
Empagliflozin | Cardiovascular benefit Cardiovascular death benefit |
Ertugliflozina | Results not available |